ClinConnect ClinConnect Logo
Search / Trial NCT06697574

Hypnotherapy for Oral Lichen Planus. Patients with Clinically and Histologically Confirmed Oral Lichen Planus Would Be Randomized for Hypnotherapy Vs Psychoeducation About the Pyschoneuroimmune System. Follow Up Would Be Done At 2, 6, 12 Weeks After.

Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Nov 19, 2024

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

Oral Lichen Planus Hypnosis

ClinConnect Summary

Background:

Lichen planus (LP) is an immune-mediated skin and mucous membrane disease that mainly affects middle-aged adults of both sexes with a slight tendency to women. The precise prevalence of LP is unknown, but it is estimated that the oral form (OLP) alone is expressed in about 1-2% of the population. OLP is a chronic disease and it is considered by the World Health Organization (WHO) as a pre-malignant condition. OLP presents in five clinical forms - reticular, plaque-like, erythematous/atrophic, erosive/ulcerative and bullous. The reticular form is the most common and is character...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Histopathologically and clinically confirmed diagnosis of OLP.
  • At least 1 year since diagnosis.
  • Above 18 years of age.
  • Fluent in Hebrew or English (for the purpose of hypnosis).
  • Lesions that are consistent with OLP are clinically visible in oral cavity.
  • Exclusion Criteria:
  • Under aged.
  • Previous negative experience with hypnosis.
  • Psychiatric diagnosis of schizophrenia, personality disorder, severe depression, or history of psychosis.
  • Substantial cognitive decline.
  • Low hypnotisability.
  • Previous oral squamous cell carcinoma.

About Tel Aviv Sourasky Medical Center

Tel Aviv Sourasky Medical Center, a leading academic medical institution in Israel, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a multidisciplinary approach, the center integrates cutting-edge medical technology and evidence-based practices to enhance patient care and outcomes. Its robust infrastructure supports a diverse range of clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. The center's dedication to research excellence and patient safety positions it as a key player in the global clinical research landscape, driving advancements in medical knowledge and treatment options.

Locations

Tel Aviv, , Israel

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported